http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201100440-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
filingDate 2009-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201100440-A1
titleOfInvention COMPOUNDS, COMPOSITIONS AND METHODS OF THEIR APPLICATION FOR CORRECTION OF URIC ACID LEVEL
abstract Disclosed are compounds useful for regulating the level of uric acid in the blood, pharmaceutical compositions containing them, as well as methods for their manufacture and use. In some implementations, the described compounds are used to treat or prevent disorders associated with abnormal levels of uric acid in the body.
priorityDate 2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175

Total number of triples: 34.